Manning W G
Department of Health Studies, University of Chicago, Ill 60637, USA.
J Clin Psychiatry. 1999;60 Suppl 3:54-6; discussion 57-8.
The assignment of costs in a cost-effectiveness analysis is a complex and disputed issue. The Panel on Cost-Effectiveness in Health and Medicine was convened to discuss standards that could be applied across a range of areas of cost-effectiveness. Additionally, the Panel had a mandate to resolve some controversial issues about the practice of cost-effectiveness that created difficulty in making comparisons across studies. The Panel proposed these guidelines: (1) Do at least some of the analysis from a social perspective; (2) Assign values to resources that reflect their opportunity costs; (3) Avoid zero counting of resources; (4) Avoid double counting of resources; (5) Make analyses only as exacting as necessary in a study. Difficulties in data collection were discussed. Among other questions considered by the panel were how to assign a value to the patient's time and which productivity costs to include in a cost-effectiveness analysis. With tools and suggestions from the Panel on Cost-Effectiveness in Health and Medicine, the cost analyst can report costs accurately and provide accurate comparisons of cost performance across states, trial modalities, or diseases.
在成本效益分析中,成本的分配是一个复杂且存在争议的问题。健康与医学成本效益小组召开会议,讨论可应用于一系列成本效益领域的标准。此外,该小组的任务是解决一些有关成本效益实践的争议性问题,这些问题给跨研究比较带来了困难。该小组提出了以下指导方针:(1)至少从社会角度进行部分分析;(2)为资源赋予反映其机会成本的价值;(3)避免对资源进行零计算;(4)避免对资源进行重复计算;(5)在研究中仅进行必要的精确分析。会议讨论了数据收集方面的困难。该小组考虑的其他问题包括如何为患者的时间赋值,以及在成本效益分析中应纳入哪些生产力成本。借助健康与医学成本效益小组提供的工具和建议,成本分析师能够准确报告成本,并对不同州、试验方式或疾病的成本绩效进行准确比较。